Similar results were obtained by Cantó et al. In a 2-year follow-up study, plasma NfL levels were higher in MS patients than in healthy controls and were associated with T2 lesion load in MRI examination, as well as a number of gadolinium-enhancing T1 lesions [81]. This evidence concerns the gene NEFL and myeloid sarcoma.